ARKG
Exchange-traded product on NYSE (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Nov 18, 2026
The full portfolio the fund publishes every business day on its website (assets.ark-funds.com). Every line is listed: holdings we could identify link to their page, the rest (cash, options, swaps, private shares, securities we do not carry) are shown as the fund prints them. Short positions are negative. Change is the share count against Nov 17, 2026.
34 lines, 33 linked, weights sum to 99.99% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| TEMPUS AI INC-CL A | TEM 88023B103 | Equity | 2,761,952 | −39,975 | 9.63% | $ 175.191M |
| TWIST BIOSCIENCE CORP | TWST 90184D100 | Equity | 1,381,558 | +11,337 | 8.50% | $ 154.734M |
| 10X GENOMICS INC-CLASS A | TXG 88025U109 | Equity | 2,480,914 | −145,124 | 7.68% | $ 139.675M |
| CRISPR THERAPEUTICS AG | CRSP H17182108 | Equity | 2,376,723 | 0 | 5.24% | $ 95.425M |
| GUARDANT HEALTH INC | GH 40131M109 | Equity | 651,785 | −9,425 | 5.13% | $ 93.388M |
| ELI LILLY & CO | LLY 532457108 | Equity | 64,741 | −936 | 5.04% | $ 91.644M |
| ILLUMINA INC | ILMN 452327109 | Equity | 419,496 | −6,071 | 4.67% | $ 84.994M |
| ABSCI CORP | ABSI 00091E109 | Equity | 10,883,235 | −157,547 | 4.53% | $ 82.495M |
| NATERA INC | NTRA 632307104 | Equity | 283,446 | −4,095 | 4.48% | $ 81.482M |
| CAREDX INC | CDNA 14167L103 | Equity | 906,349 | −13,117 | 3.71% | $ 67.577M |
| BEAM THERAPEUTICS INC | BEAM 07373V105 | Equity | 3,173,277 | −45,929 | 3.60% | $ 65.528M |
| SCHRODINGER INC | SDGR 80810D103 | Equity | 2,429,434 | −35,165 | 3.43% | $ 62.339M |
| ADAPTIVE BIOTECHNOLOGIES | ADPT 00650F109 | Equity | 1,974,865 | −28,587 | 3.09% | $ 56.264M |
| COMPASS PATHWAYS PLC | CMPS 20451W101 | Equity | 5,902,847 | −85,449 | 2.59% | $ 47.105M |
| VERACYTE INC | VCYT 92337F107 | Equity | 1,853,663 | −26,832 | 2.47% | $ 44.914M |
| RECURSION PHARMACEUTICALS-A | RXRX 75629V104 | Equity | 16,490,709 | −238,719 | 2.46% | $ 44.855M |
| NURIX THERAPEUTICS INC | NRIX 67080M103 | Equity | 2,790,715 | −40,391 | 2.18% | $ 39.74M |
| PRIME MEDICINE INC | PRME 74168J101 | Equity | 10,107,354 | −146,315 | 2.13% | $ 38.812M |
| ALAMAR BIOSCIENCES INC | ALMR 010911105 | Equity | 1,207,894 | −17,485 | 2.03% | $ 37.01M |
| INTELLIA THERAPEUTICS INC | NTLA 45826J105 | Equity | 3,497,291 | 0 | 1.88% | $ 34.204M |
| BUTTERFLY NETWORK INC | BFLY 124155102 | Equity | 5,308,710 | −76,843 | 1.68% | $ 30.525M |
| GENEDX HOLDINGS CORP | WGS 81663L200 | Equity | 622,315 | −9,009 | 1.62% | $ 29.429M |
| IONIS PHARMACEUTICALS INC | IONS 462222100 | Equity | 943,418 | −13,650 | 1.40% | $ 25.435M |
| ARCTURUS THERAPEUTICS HOLDIN | ARCT UQ 03969T109 | Equity | 3,174,891 | −45,955 | 1.39% | $ 25.304M |
| SCRIBE THERAPEUTICS INC | SCTX 811033109 | Equity | 1,597,118 | −2,771 | 1.38% | $ 25.187M |
| IAMBIC THERAPEUTICS INC | IAM 45076A101 | Equity | 1,748,162 | −25,298 | 1.37% | $ 24.859M |
| PACIFIC BIOSCIENCES OF CALIF | PACB 69404D108 | Equity | 12,542,409 | 0 | 1.25% | $ 22.827M |
| 908 DEVICES INC | MASS 65443P102 | Equity | 2,120,183 | −30,693 | 1.09% | $ 19.909M |
| FREENOME INC | FRNM 35661P100 | Equity | 1,851,391 | −26,793 | 1.00% | $ 18.181M |
| GENERATE BIOMEDICINES INC | GENB 370920100 | Equity | 1,700,605 | −24,609 | 0.92% | $ 16.734M |
| CERUS CORP | CERS 157085101 | Equity | 8,308,352 | 0 | 0.87% | $ 15.786M |
| KYMERA THERAPEUTICS INC | KYMR 501575104 | Equity | 127,214 | −1,833 | 0.85% | $ 15.459M |
| QUANTUM-SI INC | QSI 74765K105 | Equity | 7,523,110 | −108,901 | 0.42% | $ 7.598M |
|
GOLDMAN FS TRSY OBLIG INST 468
|
X9USDGSFT | Money market | 5,057,760 | +3,086,623 | 0.28% | $ 5.058M |